中国寄生虫学与寄生虫病杂志 ›› 2020, Vol. 38 ›› Issue (2): 245-249.doi: 10.12140/j.issn.1000-7423.2020.02.018
收稿日期:
2019-07-02
出版日期:
2020-04-30
发布日期:
2020-05-11
通讯作者:
陈耀凯
作者简介:
何小庆(1990-),女,硕士,医师,从事艾滋病临床及研究。E-mail:dr. 基金资助:
Xiao-qing HE, Min LIU, Lu ZHOU, Yao-kai CHEN*()
Received:
2019-07-02
Online:
2020-04-30
Published:
2020-05-11
Contact:
Yao-kai CHEN
Supported by:
摘要:
内脏利什曼病是全球被忽视的传染病之一,危害严重。而利什曼原虫-人类免疫缺陷病毒(human immunodeficiency virus,HIV)合并感染对流行地区造成的威胁更甚。利什曼原虫与HIV存在相互作用,合并感染者在临床表现、诊断及治疗方面具有一定特殊性,其病死率及复发率均高于HIV阴性的内脏利什曼病患者。本文对利什曼原虫-HIV合并感染患者的临床表现、诊断和治疗进展进行综述。
中图分类号:
何小庆, 刘敏, 周璐, 陈耀凯. 内脏利什曼病合并HIV感染患者诊断和治疗研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(2): 245-249.
Xiao-qing HE, Min LIU, Lu ZHOU, Yao-kai CHEN. Advances in diagnostics and treatment of visceral leishmaniasis co-infected with HIV[J]. Chinese Journal of Parasitology and Parasitic Diseases, 2020, 38(2): 245-249.
[1] | Lindoso JAL, Moreira CHV, Cunha MA , et al. Visceral leishmaniasis and HIV coinfection: current perspectives[J]. HIV AIDS, 2018,10:193-201. |
[2] | Zhong YY, Wang JY . Clinical analysis of AIDS coinfected with visceral leishmaniasis[J]. Chin J Prac Med, 2004,4(16):41-42. (in Chinese) |
( 钟玉映, 王俊云 . 艾滋病合并感染黑热病的临床分析[J]. 中华实用医药杂志, 2004,4(16):41-42.) | |
[3] | Gu Y, Ma CH, Zhou LB . HIV positive patient coinfected with visceral leishmaniasis:a case report[J]. JPMT, 2008(16):2156-2157. (in Chinese) |
( 古月, 马纯华, 周利波 . HIV抗体阳性患者感染黑热病1例[J]. 实用医技杂志, 2008(16):2156-2157.) | |
[4] | Zhang GX, Cao BL , Xing JY. HIV coinfected with visceral leishmaniasis:a case report [J]. Chin J Derm Venereol, 2010, 24(11): 1072, 1074. (in Chinese) |
( 张更新, 曹碧兰, 幸建英 . 艾滋病合并感染黑热病1例[J]. 中国皮肤性病学杂志, 2010, 24(11): 1072, 1074.) | |
[5] | Xia HJ, Yi YL, Liao YQ . Analysis of misdiagnosis about three cases with leishmaniasis and HIV co-infection[J]. Chin J Derm Venereol, 2011,25(7):567-568. (in Chinese) |
夏洪娇, 易运林, 廖永强 . 黑热病合并HIV感染3例误诊分析[J]. 中国皮肤性病学杂志, 2011,25(7):567-568. | |
[6] | Baoyixiamu·ABBKL, Pan KJ Maimaitiaili·XBL , et al. AIDS with kala-azar:a case report[J]. Chin J Viral Dis, 2012,2(6):75-76. (in Chinese) |
( 包依夏姆·阿巴拜克力, 潘珂君 买买提艾力·吾布力, , 等. 艾滋病合并黑热病1例分析[J]. 中国病毒病杂志, 2012,2(6):75-76.) | |
[7] | Song SH, Gui XE . Follow-up of a patient with Leishmania and human immunodeficiency virus co-infection who received prolonged sodium stibogluconate treatments[J]. Chin J Parasitol Parasit Dis, 2018,36(2):148-152. (in Chinese) |
( 宋世会, 桂希恩 . 葡萄糖酸锑钠长疗程治疗1例利什曼原虫与人类免疫缺陷病毒合并感染患者的追踪观察[J]. 中国寄生虫学与寄生虫病杂志, 2018,36(2):148-152.) | |
[8] | Guan LR, Gao CH . Leishmaniasis and its control[J]. Chin J Parasitol Parasit Dis, 2018,36(4):418-424, 428. (in Chinese) |
( 管立人, 高春花 . 利什曼病及其防治[J]. 中国寄生虫学与寄生虫病杂志, 2018,36(4):418-424, 428.) | |
[9] | Lindoso JA ,Cota GF, da Cruz AM, et al. Visceral leishmaniasis and HIV coinfection in Latin America[J]. PLoS Negl Trop Dis, 2014,8(9):e3136. |
[10] | Lima IP, Müller MC ,HolandaTA, et al. Human immunodeficiency virus/Leishmania infantum in the frst foci of urban American visceral leishmaniasis: clinical presentation from 1994 to 2010[J]. Rev Soc Bras Med Trop, 2013,46(2):156-160. |
[11] | Wang J, Guan LR . Leishmaniasis and HIV coinfection:a problem of leishmaniasis[J]. Foreign Med Sci Parasit Dis, 2004,31(4):169-172. (in Chinese) |
( 王捷, 管立人 . 利什曼原虫与艾滋病病毒的合并感染: 利什曼病防治上值得重视的一个问题[J]. 国外医学(寄生虫病分册), 2004,31(4):169-172.) | |
[12] | Cota GF, de Sousa MR, de Mendonça AL , et al. Leishmania-HIV coinfection: clinical presentation and outcomes in an urban area in Brazil[J]. LoS Negl Trop Dis, 2014,8(4):e2816. |
[13] | WHO. Control of the leishmaniases[R]. Geneva: World Health Organization, 2010. |
[14] | Srivastava P, Dayama A, Mehrotra S , et al. Diagnosis of visceral leishmaniasis[J]. Trans R Soc Trop Med Hyg, 2011,105(1):1-6. |
[15] | Burza S, Croft SL, Boelaert M . Leishmaniasis--author’s reply[J]. Lancet, 2019,393(10174):872-873. |
[16] | Nuzum E, White F, Thakur C , et al. Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood[J]. J Infect Dis, 1995,171(3):751-754. |
[17] | de Ruiter CM, van der Veer C, Leeflang MM , et al . Molecular tools for diagnosis of visceral leishmaniasis: systematic review and meta-analysis of diagnostic test accuracy[J]. J Clin Microbiol, 2014,52(9):3147-3155. |
[18] | Mary C, Faraut F, Lascombe L , et al. Quantifcation of Leishmania infantum DNA by a real-time PCR assay with high sensitivity[J]. J Clin Microbiol, 2004,42:5249-5255. |
[19] | Bourgeois N, Bastien P, Reynes J , et al. ‘Active chronic visceral leishmaniasis’ in HIV-1-infected patients demonstrated by biological and clinical long-term followup of 10 patients[J]. HIV Med, 2010,11(10):670-673. |
[20] | Cota GF, de Sousa MR, Demarqui FN , et al . The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: meta-analysis[J]. PLoS Negl Trop Dis, 2012,6(5):e1665. |
[21] | Cunningham J, Hasker E, Das P , et al. A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis[J]. Clin Infect Dis, 2012,55(10):1312-1319. |
[22] | Cota GF, de Sousa MR, Nogueira BM , et al . Comparison of parasitological, serological, and molecular tests for visceral leishmaniasis in HIV-infected patients: a cross-sectional delayed-type study[J]. Am J Trop Med Hyg, 2013,89(3):570-577. |
[23] | Riera C, Fisa R, Lopez P , et al. Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and post-treatment follow-up[J]. Eur J Clin Microbiol Infect Dis, 2004,23(12):899-904. |
Frézard F, Demicheli C, Ribeiro RR . Pentavalent antimonials: new perspectives for old drugs[J]. Molecules, 2009,14(7):2317-2336. | |
[24] | Croft SL, Yardley V . Chemotherapy of leishmaniasis[J]. Curr Pharm Des, 2002,8(4):319-342. |
[26] | Pintado V, López-Vélez R . HIV-associated visceral leishmaniasis[J]. Clin Microbiol Infect, 2001,7(6):291-300. |
[27] | Cota GF, de Sousa MR, Fereguetti TO , et al . Effcacy of antiLeishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison[J]. PLoS Negl Trop Dis, 2013,7(5):e2195. |
[28] | Ritmeijer K, Dejenie A, Assefa Y , et al. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection[J]. Clin Infect Dis, 2006,43(3):357-364. |
[29] | World Heath Organization . Control of the leishmaniases[M]. Geneva: WHO, 2010. |
[30] | Sinha PK, van Griensven J, Pandey K , et al . Liposomal amphotericin B for visceral leishmaniasis in human immunodefciency virus-coinfected patients: 2-year treatment outcomes in Bihar, India[J]. Clin Infect Dis, 2011,53(7):e91-e98. |
[31] | Balasegaram M, Ritmeijer K, Lima MA , et al. Liposomal amphotericin B as a treatment for human leishmaniasis[J]. Expert Opin Emerg Drugs, 2012,17(4):493-510. |
[32] | Sundar S, Singh A . Chemotherapeutics of visceral leishmaniasis: present and future developments[J]. Parasitology, 2018,145(4):481-489. |
[33] | Dorlo TP, Huitema AD, Beijnen JH , et al. Optimal dosing of miltefosine in children and adults with visceral leishmaniasis[J]. Antimicrob Agents Chemother, 2012,56(7):3864-3872. |
[34] | Sindermann H, Engel KR, Fischer C , et al. Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection[J]. Clin Infect Dis, 2004,39(10):1520-1523. |
[35] | Garg R, Tremblay MJ . Miltefosine represses HIV-1 replication in human dendritic cell/T-cell cocultures partially by inducing secretion of type-I interferon[J]. Virology, 2012,432(2):271-276. |
[36] | Hendrickx S, Boulet G, Mondelaers A , et al. Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum[J]. Parasitol Res, 2014,113(5):1875-1881. |
[37] | Singh N, Kumar M, Singh RK . Leishmaniasis: current status of available drugs and new potential drug targets[J]. Asian Pac J Trop Med, 2012,5(6):485-497. |
[38] | Kuhlencord A, Maniera T, Eibl H , et al. Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice[J]. Antimicrob Agents Chemother, 1992,36(8):1630-1634. |
[39] | Mahajan R, Das P, Isaakidis P , et al. Combination treatment for visceral leishmaniasis patients coinfected with human immunodefciency virus in India[J]. Clin Infect Dis, 2015,61(8):1255-1262. |
[40] | López-Vélez R, Videla S, Márquez M , et al. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients[J]. J Antimicrob Chemother, 2004,53(3):540-543. |
[41] | Molina I, Falcó V, Crespo M , et al. Effcacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients[J]. J Antimicrob Chemother, 2007,60(4):837-842. |
[42] | Diro E, Ritmeijer K, Boelaert M , et al. Use of pentamidine as secondary prophylaxis to prevent visceral leishmaniasis relapse in HIV infected patients, the first twelve months of a prospective cohort study[J]. PLoS Negl Trop Dis, 2015,9(10):e0004087. |
[43] | Marques N, Sá R, Coelho F , et al. Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients[J]. Scand J Infect Dis, 2008,40(6/7):523-526. |
[44] | Burza S, Mahajan R, Sinha PK , et al. Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome)[J]. PLoS Negl Trop Dis, 2014,8(8):e3053. |
[45] | van Griensven J, Diro E, Lopez-Velez R , et al. HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals[J]. Lancet Infect Dis, 2013,13(3):251-259. |
[1] | 陈睿, 袁琼辉, 夏万宝. 1例罕见原发性阿米巴脑膜脑炎病例的实验室诊断[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(5): 616-621. |
[2] | 秦敏, 王立英. 阿苯达唑联合药物治疗棘球蚴病的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(5): 647-655. |
[3] | 刘继兵, 赵洪喜. 基于18S rRNA的胎毛滴虫感染PCR诊断方法的建立[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(5): 682-685. |
[4] | 国家传染病医学中心撰写组. 疟疾诊疗指南[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 419-427. |
[5] | 曹磊, 马琳, 朱妮, 张义, 王安礼, 王舒, 李欣欣. 2011—2020年陕西省疟疾流行特征[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 454-459. |
[6] | 杨成运, 贺志权, 鲁德领, 钱丹, 刘颖, 李素华, 周瑞敏, 邓艳, 张红卫, 王昊, 赵东阳, 郭万申. 2020年河南省内脏利什曼病病例的流行病学调查[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 481-486. |
[7] | 乔飞, 刘鏊, 余复昌, 齐萌. 1例牛带绦虫感染的诊断和鉴定[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(3): 285-287. |
[8] | 朱名超, 朱娅. HIV合并人芽囊原虫和蓝氏贾第鞭毛虫感染1例[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(3): 315-318. |
[9] | 罗卓韦, 周正斌, 公衍峰, 冯家鑫, 李元元, 张仪, 李石柱. 我国内脏利什曼病的流行现状和防控挑战[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(2): 146-152. |
[10] | 赵紫琪, 吕芳丽. 免疫功能健全者获得性弓形虫病的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(2): 228-235. |
[11] | 张爱平, 梁曼曼, 朱玲玲, 盛皓宇, 杨江华. 内脏利什曼病治疗后64年复发1例[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(2): 266-268. |
[12] | 蔡子涵, 曹颖, 朱逢龙, 李倩, 和艳红, 杨毅梅. 纳米金棒标记技术应用于旋毛虫感染诊断的研究[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(5): 652-658. |
[13] | 张耀光, 江莉, 王真瑜, 朱民, 朱倩, 马晓疆, 吴寰宇. 上海市2例输入性卵形疟误诊病例的实验室诊断分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(4): 553-556. |
[14] | 郑玉华, 白永飞, 帖萍, 闫昌福, 王婷, 王晶莹, 王三桃, 蔡剑. 2010—2019年山西省人群内脏利什曼病流行特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(3): 352-358. |
[15] | 黄子芸, 吕芳丽. 实体器官移植与弓形虫病[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(3): 386-392. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||